The entries of “Technologies made in Vienna” are displayed in the project language.
Technologies from Vienna
Medical biotechnologyLexogen is a biotech company with a unique, proprietory technology portfolio enabling the detailed analysis of complete transcriptomes as well as of individual RNAs.
Highlights are cost-efficient gene expression analysis kits and services, also for time-resolved applications, external NGS controls, and sample preparations for the upcoming, 3rd generation of high-throughput sequencers.
Lexogen was founded in 2007 with the support of both private capital and public funds.
Kontakt Wirtschaftsagentur Wien
Information and networking are co-funded by the European Fund for regional development as part of the „IC3 Innovation by Co-Operation, Co-Creation and Community Building“ project. Additional information on the IWB/EFRE funding programme